Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Vital Therapies logo

About Vital Therapies Stock (NASDAQ:VTL)

Key Stats

Today's Range
$1.14
$1.28
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
1.14 million shs
Average Volume
21.62 million shs
Market Capitalization
$48.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

VTL Stock News Headlines

Lighthouse Center for Vital Living celebrates new building
America is losing power
A massive energy crisis is here … And it’s all because of artificial intelligence. You see, on average, just one new AI data center currently requires the same amount of electricity needed to power 750,000 homes.
Vardhman Textiles Ltd.
See More Headlines

VTL Stock Analysis - Frequently Asked Questions

Vital Therapies, Inc. (NASDAQ:VTL) issued its earnings results on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Bristol-Myers Squibb (BMY), Novavax (NVAX) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/07/2018
Today
11/12/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$48.73 million
Optionable
Not Optionable
Beta
3.51
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:VTL) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners